Value of point-of-care ultrasound in the early identification of left ventricular dysfunction and prognostic assessment in cancer patients complicated by sepsis - Scorecard - MDSpire
Advertisement
Value of point-of-care ultrasound in the early identification of left ventricular dysfunction and prognostic assessment in cancer patients complicated by sepsis
Clinical Scorecard: Role of Point-of-Care Ultrasound in Early Detection of Left Ventricular Dysfunction and Prognostic Evaluation in Cancer Patients with Sepsis Complications
At a Glance
Category
Detail
Condition
Sepsis-induced myocardial dysfunction (SIMD) in cancer patients
Key Mechanisms
Left ventricular dysfunction assessed via point-of-care ultrasound (POCUS)
Target Population
Adult cancer patients complicated by sepsis
Care Setting
Emergency Intensive Care Unit (EICU)
Key Highlights
Patients with LV dysfunction (LVEF < 50%) had higher 28-day mortality rates.
e' velocity identified as an independent predictor of 28-day survival.
Combination of e' and cardiac troponin I (cTnI) showed strong predictive value.
Composite prognostic model achieved highest predictive accuracy (AUC = 0.874).
Study emphasizes the need for early identification of cardiac dysfunction in septic cancer patients.
Guideline-Based Recommendations
Diagnosis
Utilize POCUS to assess left ventricular function in cancer patients with sepsis.
Management
Implement targeted therapeutic interventions based on POCUS findings.
Monitoring & Follow-up
Regularly assess LV function and cardiac biomarkers in septic cancer patients.
Risks
Higher mortality associated with sepsis-induced myocardial dysfunction.
Patient & Prescribing Data
Adult cancer patients with sepsis admitted to EICU.
Early measurement of e' may help identify high-risk patients.
Clinical Best Practices
Incorporate POCUS in the routine evaluation of cardiac function in septic patients.
Monitor e' velocity and cardiac troponin I levels for prognostic assessment.
